Joseph Frattaroli - Cheif Financial Officer at Inhibikase Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Cheif Financial Officer
Stock Symbol
IKT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Joseph Frattaroli since 11/12/2023

Holdings reported by Joseph Frattaroli for Inhibikase Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 48.1K $38.5K $0.80 Mar 1, 2023 Direct
Stock Option (right to buy) 90K Mar 1, 2023 Direct Common Stock

Transactions reported by Joseph Frattaroli for Inhibikase Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.